Kangmei Pharmaceutical Co., Ltd. plans to set up 6 companies with 190 million yuan and 30 million Australian dollars

[China Pharmaceutical network enterprise news] Kangmei pharmaceutical announced in the evening of July 19 that the company plans to invest 190 million yuan and 30 million Macao dollars to set up six companies   The investment amounts are respectively 30 million Macao dollars of Kangmei (Macao) traditional Chinese medicine Trading Center Co., Ltd., 50 million yuan of Kangmei (Tongliao) Hospital Investment Co., Ltd., 30 million yuan of Kangmei (Tongliao) Hospital Management Co., Ltd., 10 million yuan of Kangmei (Hengqin) traditional Chinese Medicine Innovation Research Institute Co., Ltd., 50 million yuan of Kangmei (Hengqin) traditional Chinese medicine Trading Center Co., Ltd., and 50 million yuan of Kangmei hospital investment (Jilin) Co., Ltd The company is RMB 50 million Kangmei pharmaceutical said that the company's foreign investment in the establishment of six companies is the demand of the company's strategic layout and business development, which is conducive to promoting the further expansion of the company's pharmaceutical logistics extension service projects and online transactions of traditional Chinese medicine, improving the company's R & D capacity and promoting the internationalization level of traditional Chinese medicine   Among them, Tongliao hospital investment company and Tongliao hospital management company will undertake the medical logistics extension service project and hospital construction investment project in Tongliao City, Inner Mongolia; Macao traditional Chinese medicine trading company and Hengqin traditional Chinese medicine trading company will rely on the operation and management experience of the company's traditional Chinese medicine trading platform (e Medicine Valley) to carry out online traditional Chinese medicine trading services in Macao and Hengqin; Hengqin Chuang The new research institute will promote the research and development of traditional Chinese medicine with the policy support of Guangdong Australia cooperative TCM science and Technology Industrial Park in Hengqin new area; Jilin hospital investment company will undertake the construction investment project of Meihekou hospital Kangmei pharmaceutical industry, from the leader of the whole industry of traditional Chinese medicine to the leader of medicine circulation and service, is building a pharmaceutical manufacturing + service giant with Chinese model In the past, the growth of business has been mainly driven by the pure traditional Chinese medicine industry to a situation of multi business collaboration This large-scale investment in the establishment of six companies will further consolidate the company's leading position in traditional Chinese medicine.